US2022220191A1PendingUtilityA1
Method for improving affinity of antibody for antigen and use thereof
Est. expiryJan 24, 2040(~13.5 yrs left)· nominal 20-yr term from priority
C07K 2317/622C07K 2317/569C07K 2317/55C07K 2317/54C07K 2317/51C07K 16/2863C07K 16/40G16B 20/30G16B 15/20C07K 2317/515C07K 2317/567C07K 16/32C07K 16/26C07K 16/00C07K 2317/24C07K 2317/92
77
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
The present invention relates to a method for improving affinity of an antibody for an antigen. The present invention relates to a method for producing an antibody with improved affinity for an antigen as compared to an unmodified antibody. The present invention relates to a modified antibody with improved affinity for an antigen as compared to an unmodified antibody.
Claims
exact text as granted — not AI-modified1 . A method for improving affinity of an antibody for an antigen, comprising:
in an unmodified antibody, improving affinity for an antigen as compared to the unmodified antibody, by changing at least 3 amino acid residues selected from a group consisting of 60th, 63rd, 65th, 67th, 70th, 72nd, 74th, 76th, 77th, 79th and 81st amino acid residues of a light chain defined by Kabat method to charged amino acid residues, wherein the 3 amino acid residues contain at least one selected from a group consisting of 60th, 74th, 76th, 77th, 79th and 81st amino acid residues of the light chain.
2 . A method for producing an antibody with improved affinity for an antigen as compared to an unmodified antibody, comprising:
in an unmodified antibody, changing at least 3 amino acid residues selected from a group consisting of 60th, 63rd, 65th, 67th, 70th, 72nd, 74th, 76th, 77th, 79th and 81st amino acid residues of a light chain defined by Kabat method to charged amino acid residues; and recovering the antibody obtained in the changing, wherein the 3 amino acid residues contain at least one selected from a group consisting of 60th, 74th, 76th, 77th, 79th and 81st amino acid residues of the light chain.
3 . The method according to claim 1 or 2 , wherein the at least 3 amino acid residues are selected from the group consisting of 60th, 74th, 76th, 77th, 79th and 81st amino acid residues of the light chain.
4 . The method according to any one of claims 1 to 3 , wherein the at least 3 amino acid residues are 60th, 76th, and 77th amino acid residues of the light chain.
5 . A modified antibody with improved affinity for an antigen as compared to an unmodified antibody, wherein
at least 3 amino acid residues selected from a group consisting of 60th, 63rd, 65th, 67th, 70th, 72nd, 74th, 76th, 77th, 79th and 81st amino acid residues of a light chain defined by Kabat method in the unmodified antibody are changed to charged amino acid residues, and the 3 amino acid residues contain at least one selected from a group consisting of 60th, 74th, 76th, 77th, 79th and 81st amino acid residues of the light chain.
6 . The modified antibody according to claim 5 , wherein the at least 3 amino acid residues are at least 3 selected from the group consisting of 60th, 74th, 76th, 77th, 79th and 81st amino acid residues of the light chain.
7 . The modified antibody according to claim 5 or 6 , wherein the at least 3 amino acid residues are 60th, 76th and 77th amino acid residues of the light chain.
8 . The method according to any one of claims 1 to 4 , or the modified antibody according to any one of claims 5 to 7 , wherein the charged amino acid residues are basic amino acid residues.
9 . The method according to any one of claims 1 to 4 and 8 , or the modified antibody according to any one of claims 5 to 8 , which is in a form of an antibody fragment.
10 . The method or modified antibody according to claim 9 , wherein the antibody fragment is a Fab fragment, a F(ab′)2 fragment, a Fab′ fragment, a Fd fragment, a Fv fragment, a dAb fragment, scFv, or rIgG.Join the waitlist — get patent alerts
Track US2022220191A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.